Cost-effectiveness of ALK testing and first-line crizotinib...

Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China

Lu, Shun, Yu, Yongfeng, Fu, Shijun, Ren, Hongye, Gangopadhyay, Nupur
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0205827
Date:
October, 2018
File:
PDF, 1.22 MB
english, 2018
Conversion to is in progress
Conversion to is failed